Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study

被引:55
作者
Ambaraghassi, Georges [1 ,2 ]
Dufresne, Philippe J. [3 ]
Dufresne, Simon F. [1 ,2 ,4 ]
Vallieres, Emilie [2 ,5 ,6 ]
Munoz, Jose F. [7 ]
Cuomo, Christina A. [7 ]
Berkow, Elizabeth L. [8 ]
Lockhart, Shawn R. [8 ]
Luong, Linh [1 ,2 ]
机构
[1] CHUM, Dept Lab Med, Div Microbiol, Montreal, PQ, Canada
[2] Univ Montreal, Fac Med, Dept Microbiol Immunol & Infect Dis, Montreal, PQ, Canada
[3] Inst Natl Sante Publ Quebec, Lab Sante Publ Quebec, Montreal, PQ, Canada
[4] Hop Maison Neuve Rosemont, Div Infect Dis & Clin Microbiol, Dept Med, CIUSSS Est Ile Montreal, Montreal, PQ, Canada
[5] Ctr Hosp Univ St Justine, Dept Lab Med, Div Microbiol, Montreal, PQ, Canada
[6] Ctr Hosp Univ St Justine, Dept Pediat, Infect Dis Serv, Montreal, PQ, Canada
[7] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[8] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA
关键词
Candida auris; VITEK; 2; phenotypic identification; HAEMULONII COMPLEX; GENOME; NOV;
D O I
10.1128/JCM.00884-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida auris is an emerging multidrug-resistant yeast that has been systematically incorrectly identified by phenotypic methods in clinical microbiology laboratories. The Vitek 2 automated identification system (bioMerieux) recently included C. auris in its database (version 8.01). We evaluated the performance of the Vitek 2 YST ID card to identify C. auris and related species. A panel of 44 isolates of Candida species (C. auris, n = 35; Candida haemulonii, n = 5; Candida duobushaemulonii, n = 4) were tested by three different hospital-based microbiology laboratories. Among 35 isolates of C. auris, Vitek 2 yielded correct identification in an average of 52% of tested samples. Low-discrimination (LD) results with an inability to distinguish between C. auris, C. duobushaemulonii, and Candida famata were obtained in an average of 27% of samples. Incorrect identification results were obtained in an average of 21% of samples, the majority (91%) of which were reported as C. duobushaemulonii and the remaining 9% of which were reported as Candida lusitaniae/C. duobushaemulonii. The proportion of correct identification was not statistically different across different centers (P = 0.78). Stratification by genetic clades demonstrated that 100% (n = 8) of the strains of the South American Glade were correctly identified compared to 7% (n = 10) and 0% (n = 4) from the African and East Asian clades, respectively. None of the non-auris Candida strains (n = 9) were incorrectly identified as C. curls. Our results show that the Vitek 2 (version 8.01) yeast identification system has a limited ability to correctly identify C. auris. These data suggest that an identification result for C. duobushaemulonii should warrant further testing to rule out C. auris. The overall performance of the Vitek 2 seems to differ according to C. curls genetic Glade, with the South American isolates yielding the most accurate results.
引用
收藏
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 2017, GUID LAB INV MAN INF
[2]   Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples [J].
Arastehfar, Amir ;
Fang, Wenjie ;
Daneshnia, Farnaz ;
Al-Hatmi, Abdullah M. S. ;
Liao, Wanqing ;
Pan, Weihua ;
Khan, Ziauddin ;
Ahmad, Suhail ;
Rosam, Katharina ;
Lackner, Michaela ;
Lass-Floerl, Cornelia ;
Hagen, Ferry ;
Boekhout, Teun .
FUTURE MICROBIOLOGY, 2019, 14 (01) :33-45
[3]   Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives [J].
Arastehfar, Amir ;
Fang, Wenjie ;
Badali, Hamid ;
Vaezi, Afsane ;
Jiang, Weiwei ;
Liao, Wanqing ;
Pan, Weihua ;
Hagen, Ferry ;
Boekhout, Teun .
FRONTIERS IN MICROBIOLOGY, 2018, 9
[4]  
Arendrup MC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00485-17, 10.1128/AAC.00485-17]
[5]   First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia [J].
Calvo, Belinda ;
Melo, Analy S. A. ;
Perozo-Mena, Armindo ;
Hernandez, Martin ;
Francisco, Elaine Cristina ;
Hagen, Ferry ;
Meis, Jacques F. ;
Colombo, Arnaldo Lopes .
JOURNAL OF INFECTION, 2016, 73 (04) :369-374
[6]   Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts [J].
Cendejas-Bueno, E. ;
Kolecka, A. ;
Alastruey-Izquierdo, A. ;
Theelen, B. ;
Groenewald, M. ;
Kostrzewa, M. ;
Cuenca-Estrella, M. ;
Gomez-Lopez, A. ;
Boekhout, T. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (11) :3641-3651
[7]  
Centers for Disease Control and Prevention, 2018, ALG ID CAND AUR BAS
[8]  
Centers for Disease Control and Prevention, 2017, INF PREV CONTR CAND
[9]   Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris [J].
Chatterjee, Sharanya ;
Alampalli, Shuba Varshini ;
Nageshan, Rishi Kumar ;
Chettiar, Sivarajan T. ;
Joshi, Sangeeta ;
Tatu, Utpal S. .
BMC GENOMICS, 2015, 16
[10]   Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey [J].
Chow, Nancy A. ;
Gade, Lalitha ;
Tsay, Sharon V. ;
Forsberg, Kaitlin ;
Greenko, Jane A. ;
Southwick, Karen L. ;
Barrett, Patricia M. ;
Kerins, Janna L. ;
Lockhart, Shawn R. ;
Chiller, Tom M. ;
Litvintseva, Anastasia P. .
LANCET INFECTIOUS DISEASES, 2018, 18 (12) :1377-1384